Mubadala investment company injects US$250M worth of funds into Certara

WORLD – Mubadala Investment Company (Mubadala) has made an approximately US$250 million investment in Certara as a strategy move that will enable innovation to address unmet clinical needs and drive cost efficiencies. Mubadala and certain existing institutional shareholders of Certara, including a shareholder affiliated with EQT, a private equity company, have entered into an agreement under which an affiliate of Mubadala will purchase an aggregate of 9,615,384 shares at $26 per share from the shareholders in a private transaction. The transaction is scheduled to close on August 2, 2021. EQT…

Read More